The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
RITUXIMAB Enterobacter infection 1
Rituximab Enterocolitis 1
RITUXIMAB Enterovirus infection 1
Rituximab Eosinophilia 1
Rituximab Erectile dysfunction 1
Rituximab Exfoliative rash 1
rituximab Exposure during pregnancy 1
RITUXIMAB Extranodal marginal zone B-cell lymphoma (MALT type) 1
RITUXIMAB Eye haemorrhage 1
Rituximab Facial nerve disorder 1
Rituximab Fascioliasis 1
RITUXIMAB Feeling abnormal 1
Rituximab Feeling cold 1
Rituximab Feeling hot 1
RITUXIMAB Fluid retention 1
rituximab Foetal exposure during pregnancy 1
RITUXIMAB Food contamination 1
RITUXIMAB Gait disturbance 1
rituximab Gastric ulcer perforation 1
RITUXIMAB Gastric varices 1

Total Records: 1,104     Number of Pages: 56